Article
Impact of Modifiable Risk Factors and APOE on Neuropsychiatric Symptoms in Alzheimer’s Disease
2026-06-05
Abstract excerpt
<h4>ABSTRACT</h4> <h4>BACKGROUND</h4> Neuropsychiatric symptoms (NPS) are prevalent and debilitating in Alzheimer’s disease (AD). Existing pharmacologic treatments are often ineffective and associated with serious adverse events. Identifying modifiable risk factors (MRFs) is critical for prevention and treatment. <h4>METHODS</h4> Capitalizing on data from 14,497 individuals with AD from the National Alzheimer’s...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0641d442-4258-58a9-aba4-5e50d376d0ec
- DOI
- 10.64898/2026.06.04.26353599
